Anixa Biosciences, Inc. (ANIX)
2.86
-0.06
(-2.05%)
USD |
NASDAQ |
Feb 20, 12:33
Anixa Biosciences EPS Diluted (Quarterly) : -0.0816 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.722M |
| Total Expenses (Quarterly) | 2.695M |
| Enterprise Value | 81.29M |
| Earnings Yield | -11.77% |
| Normalized Earnings Yield | -11.77 |